Joshua R. Disbrow - 09 Jun 2025 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Executive Officer
Signature
/s/ Joshua R. Disbrow
Issuer symbol
AYTU
Transactions as of
09 Jun 2025
Net transactions value
+$99,999
Form type
4
Filing time
10 Jun 2025, 15:04:30 UTC
Previous filing
16 May 2025
Next filing
07 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Disbrow Joshua R. Chief Executive Officer C/O AYTU BIOPHARMA, INC., 7900 EAST UNION AVENUE, SUITE 920, DENVER /s/ Joshua R. Disbrow 10 Jun 2025 0001566240

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Stock Purchase $99,999 +66,666 +77% $1.50 153,257 09 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025.